Open access · OA
via OpenAlex
mTOR : at the crossroads of aging, chaperones, and A lzheimer's disease
Journal of Neurochemistry · 2012 · ▲ 13 citations
Abstract
Read the full article ‘Over‐expression of heat shock factor 1 phenocopies the effect of chronic inhibition of TOR by mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">rapamycin(definition) and is sufficient to ameliorate Alzheimer's‐like deficits in mice modeling the disease’ on doi: 10.1111/jnc.12080
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1111/jnc.12098
- Canonical
- link ↗
- Fetched
- 2026-10-07 MST
Cite this
APA
Gouras, G.K. (2012). mTOR : at the crossroads of aging, chaperones, and A lzheimer's disease. <em>Journal of Neurochemistry</em>. https://doi.org/10.1111/jnc.12098
Vancouver
Gouras GK. mTOR : at the crossroads of aging, chaperones, and A lzheimer's disease. Journal of Neurochemistry. 2012. doi:10.1111/jnc.12098.
BibTeX
@article{gunnar2012mTORat,
title = {mTOR : at the crossroads of aging, chaperones, and A lzheimer's disease},
author = {Gunnar K. Gouras},
journal = {Journal of Neurochemistry},
year = {2012},
doi = {10.1111/jnc.12098},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Nature Reviews Neurology 2024
Preprint · OA
Is Alzheimer disease a disease?
Reunião de Pesquisadores em Doença de Alzheimer e Desordens Relacionadas (RPDA) 2024
Open access · OA
Neurodevelopmental transcriptomic signature in elderly with Alzheimer’s disease
The Lancet 2021
Preprint · OA
Alzheimer's disease
Handbook of clinical neurology 2019
Citation only
Alzheimer's disease
Neuron 2013
Open access · OA
Biomarker Modeling of Alzheimer’s Disease
Biological Psychiatry 2020
Open access · OA